| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8441288 | European Journal of Cancer | 2016 | 7 Pages |
Abstract
Cetuximab-FOLFOX regimen combined with radiotherapy demonstrated its efficacy and was well tolerated. Unfortunately, these results were not confirmed in two recent phase III studies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Gérard Lledo, Florence Huguet, Benoist Chibaudel, Frédéric Di Fiore, Laurent Mineur, Marie-Pierre Galais, Pascal Artru, Valérie Blondin, Olivier Dupuis, Menouar Samir Abdiche, Nicolas Jovenin, Astrid Pozet, Franck Bonnetain, Mohamed Attia,